The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE)

Autor: Yousuf, Muhammad Saad, Zubkow, Kasia, Tenorio, Gustavo, Kerr, Bradley

Publikováno v: In Neuroscience 6 March 2017 344:178-186

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Dynamic Expansion and Contraction of Multiple Sclerosis T2-weighted Hyperintense Lesions are Present Below the Threshold of Visual Perception.

Autor: Okuda DT; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Moog TM; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., McCreary M; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Shan K; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Zubkow K; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Newton BD; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Smith AD; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Patel MA; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Burgess KW; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France., Lebrun-Frénay C; From the Department of Neurology, Neuroinnovation Program, Multiple Sclerosis and Neuroimmunology Imaging Program, The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute (DTO, TMM, MM, MAP, KWB), Dallas Texas, USA; The University of Texas Southwestern Medical Center, School of Medicine (KS), Dallas, Texas, USA; Division of Neurology, University of Saskatchewan (KZ), Saskatoon, SK, Canada; Division of Neurosurgery, University of Saskatchewan (BDN), Saskatoon, SK, Canada; Texas Tech University Health Sciences Center, School of Medicine (ADS), Lubbock, Texas, USA; Université Nice Cote d'Azur (CLF), CRCSEP, Nice, France.

Publikováno v: AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2024 Aug 16. Date of Electronic Publication: 2024 Aug 16.